MSG
TSVT

Main Street Group’s 2seventy bio TSVT Stock Holding History

Main Street Group’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-33
Closed -$164 – 828
2025
Q1 		$164 Hold
33
– – ﹤0.01% 758
2024
Q4 		$98 Hold
33
– – ﹤0.01% 757
2024
Q3 		$156 Hold
33
– – ﹤0.01% 746
2024
Q2 		$134 Hold
33
– – ﹤0.01% 846
2024
Q1 		$191 Hold
33
– – ﹤0.01% 872
2023
Q4 		$140 Buy
+33
New +$101 ﹤0.01% 1254

Other funds holding TSVT

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Main Street Group's TSVT Position: Q2 2025 in Review

Main Street Group sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 33 shares — an estimated $164 sold.

Main Street Group first reported a position in TSVT in Q4 2023 and held it in 6 quarters. The position peaked at $191 in Q1 2024. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • Main Street Group reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • Main Street Group sold 33 2seventy bio shares in Q2 2025, an estimated $164.
  • Main Street Group first reported a position in 2seventy bio in Q4 2023 and held it in 6 quarters.
  • Main Street Group's 2seventy bio position peaked at $191 in Q1 2024.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Main Street Group's 13F filing for Q2 2025, filed 15 Jul 2025.